GlassScriptPhysician profile
Kassandra Petit
NPI 1083290860
$9,577.54
in general payments reported to CMS, 2019-2025
11 companies · $593 in 2025
The $593 reported for 2025 was more than what 89% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.30 · 2022: $142 · 2023: $7,721 · 2024: $1,023 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,092 · Consulting Fee: $3,059 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,070 · Travel and Lodging: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,091.92 |
| Consulting Fee | $3,059.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,070.00 |
| Travel and Lodging | $1,115.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $7,318.82 | 2022-2025 | Veozah |
| Viiv Healthcare Company | $877.49 | 2023-2025 | Dovato, Rukobia, Cabenuva |
| Gilead Sciences, INC. | $714.65 | 2021-2025 | Biktarvy, Yeztugo |
| Merck Sharp & Dohme LLC | $379.25 | 2023-2025 | Pifeltro, Delstrigo, Dificid |
| Theratechnologies INC. | $71.10 | 2023-2024 | Egrifta, Trogarzo |
| Evofem Biosciences, INC. | $68.66 | 2022 | |
| Abbvie INC. | $63.59 | 2023-2024 | |
| Indivior INC. | $29.08 | 2024 | Sublocade |
| Novartis Pharmaceuticals Corporation | $18.43 | 2024 | |
| Janssen Biotech, INC. | $18.31 | 2023 | Symtuza |
| Coopersurgical, INC. | $18.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kassandra Petit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.